Latus Bio
Latus | Where delivery transforms treatment
United States · $54.0M raised
- Business Model
- B2B
- Website
- latusbio.com
- Total Funding
- $54.0M
- Last Round
- $54.0M Series AMay 2024
- Rounds
- 1
About
Gene therapy company developing AAV capsid variants to target CNS disorders and genetic diseases.
Summary
Latus Bio is a Biotech company based in United States. It has raised $54.0M in total across 1 round, most recently a $54.0M Series A round in May 2024. Investors include 8VC, DCVC (Data Collab) and Samsung Life Science Fund.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
May 2024
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...